Covered recipient · General Payments record
TARA NICOLE ROZIER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,115.26
- Reported across 184 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $563.53 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $257.96 | 12 |
| IRONWOOD PHARMACEUTICALS, INC | $68.22 | 2 |
| Amgen Inc. | $66.26 | 5 |
| Acerta Pharma LLC | $53.88 | 3 |
| Lilly USA, LLC | $47.31 | 3 |
| Exact Sciences Corporation | $22.23 | 1 |
| Mylan Specialty L.P. | $19.64 | 1 |
| Corcept Therapeutics | $14.50 | 1 |
| Novo Nordisk AS | $13.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.52 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120655 | CMS |
| ABBVIE INC. | $27.22 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120657 | CMS |
| ABBVIE INC. | $19.72 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120659 | CMS |
| ABBVIE INC. | $15.81 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120661 | CMS |
| ABBVIE INC. | $26.71 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120663 | CMS |
| ABBVIE INC. | $15.86 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120665 | CMS |
| ABBVIE INC. | $1.37 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120667 | CMS |
| ABBVIE INC. | $26.30 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120669 | CMS |
| ABBVIE INC. | $30.37 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120671 | CMS |
| ABBVIE INC. | $29.88 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120673 | CMS |
| ABBVIE INC. | $26.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120675 | CMS |
| ABBVIE INC. | $12.72 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108120677 | CMS |
| Amgen Inc. | $13.17 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117670955 | CMS |
| Amgen Inc. | $13.59 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117670957 | CMS |
| Amgen Inc. | $13.13 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117670959 | CMS |
| Amgen Inc. | $13.07 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117670961 | CMS |
| Amgen Inc. | $13.30 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117670963 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.64 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104568830 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.11 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105784612 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.13 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105300965 | CMS |
| Corcept Therapeutics | $14.50 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117781867 | CMS |
| Exact Sciences Corporation | $22.23 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114538669 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $21.33 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153721948 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $46.89 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153739325 | CMS |
| Lilly USA, LLC | $14.24 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959971 | CMS |
| Lilly USA, LLC | $16.11 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135963047 | CMS |
| Lilly USA, LLC | $16.96 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959973 | CMS |
| Mylan Specialty L.P. | $19.64 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147362760 | CMS |
| Novo Nordisk Inc | $13.53 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100449233 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.